The SOLACI-SOCIME 2022 Congress Is Here

Face-to-face SOLACI Congresses are back!

With a large medical attendance and significant support from the industry, SOLACI-SOCIME 2022 Congress has kicked off at the luxurious Expo Santa Fe Convention Center in the beautiful Mexico City.

After two and a half years of pandemic, we meet again to share knowledge, experiences, and lessons learned in an event of scientific excellence with state-of-the-art technology, where you can enjoy challenging live cases, keynote lectures, academic debates, and valuable sessions on the main topics of the specialty.

The vast scientific agenda for our Congress includes live streaming of 11 cases from Mexico and Argentina, participation of over 25 international speakers, 75 Latin-American speakers, and hundreds of national lecturers. Additionally, we will share specialized symposiums for fellows, pediatricians, technicians, and nurses.

In-person registration will be open during the entire event at Expo Santa Fe. In addition, sessions at the Main Arena will be broadcasted through streaming.

We hope you enjoy the event!

(Access only available for people who registered before August 1st and those awarded a scholarship).


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....